Celularity (CELU) Inventory (2020 - 2025)
Celularity (CELU) posted quarterly Inventory of $3.5 million for Q4 2025, down 34.98% year-over-year from $5.4 million in Q4 2024, and up 37.22% quarter-over-quarter from $2.6 million in Q3 2025.
Celularity (CELU) Inventory (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Inventory for 6 consecutive years, with $3.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Inventory fell 34.98% year-over-year to $3.5 million; the TTM figure through Dec 2025 stood at $3.5 million (down 34.98% YoY), while the FY2025 annual figure was $3.5 million, down 34.98% from the prior year.
- Inventory advanced to $3.5 million in Q4 2025 per CELU's latest filing, from $2.6 million in the prior quarter.
- Across five years, Inventory topped out at $24.7 million in Q2 2022 and bottomed at $2.6 million in Q3 2025.
- Historically, Inventory has averaged $7.1 million across 5 years, with a median of $5.4 million in 2023.
- Annual changes were most pronounced in 2023 — Inventory sank 76.73% — and 2025, when it soared 305.45%.
- Celularity's Inventory stood at $9.5 million in 2021, then tumbled by 44.41% to $5.3 million in 2022, then rose by 8.38% to $5.8 million in 2023, then retreated by 5.98% to $5.4 million in 2024, then tumbled by 34.98% to $3.5 million in 2025.
- Business Quant data shows CELU's Inventory at $3.5 million in Q4 2025, $2.6 million in Q3 2025, and $11.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn | 3.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.52 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 11.82 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 4.93 Mn |
| Jun 30, 2023 | 5.74 Mn |
| Mar 31, 2023 | 5.48 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 5.24 Mn |
| Jun 30, 2022 | 24.66 Mn |
| Mar 31, 2022 | 14.72 Mn |
| Dec 31, 2021 | 9.55 Mn |
| Sep 30, 2021 | 5.75 Mn |
| Dec 31, 2020 | 9.55 Mn |